Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Oct 15, 2020 7:17am
158 Views
Post# 31719658

RE:RE:RE:RE:RE:Resverlogix Announces Conversion of US$12 Million Debenture

RE:RE:RE:RE:RE:Resverlogix Announces Conversion of US$12 Million Debenture ,,,I assume its something like Togo that is interested in the PP,,,lmfao!!! Thats a country most have never heard of!

Well if there was ever a poor business model in biotech we own one,,,,,,,,they tell us 7 molecules in wait sitting with no plan or direction evident. 208 being the bread and butter for our survival,,,,,,why it was not partnered back years ago is DMcCs' entire fault,,,,if it had been our stepping stone we would have these other molecules in some advanced state imo. No business head,,no share price respect...purdy simple aint it !!

The only entities benefiting from this dragged out soap opera is our management team,,now isnt that a coincidence!!!!!!!!!!!!!!!!    :o)
<< Previous
Bullboard Posts
Next >>